Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014


15th Annual Drug Discovery Leaders Summit

02 Jun 2014 - 03 Jun 2014 - Geneva, Switzerland



Bookmark and Share


Attend Europe’s leading networking and discussion platform for drug discovery professionals.  

Meet 250 senior-level delegates from global pharmaceutical organisations, leading biotechs and esteemed academic institutions.

Hear 60 expert speakers discuss the pressing challenges in medicinal chemistry, compound screening, target-based discovery and innovation access.

Discuss the viability of the latest discovery trends, including phenotypic screening, epigenetic drug discovery, stem cell technology and nanoengineering.

Tailor your congress experience – attend any sessions from the following six streams:

- R&D Models For The Future

- Screening & Assays: Enabling Technologies

- Target Based Discovery

- Supporting Innovation: Data & Information Management

- Discovery Chemistry: Latest Case Studies

- Drug Design: Novel Approaches

The Summit is co-located with the 6th Annual Drug Development Congress - an executive level event focusing on predictive science and translational medicine.

The Drug Discovery Summit is Europe’s leading networking and discussion platform for pharmaceutical professionals. Attending this long-established event gives delegates the opportunity to:

Hear from and meet with the people shaping the pharmaceutical landscape. Previous attendees include: Vice President New Frontier Science Europe, Takeda; Vice President and Venture Leader, Janssen R&D; Vice President & Global Head, Reagents & Assay Development, AstraZeneca.

Discuss the latest discovery innovations, including 3D cell based assays, advances in nanoengineering and iPSCs for compound screening.

Discover collaborative solutions to discovery challenges. This summit brings together a host of experts to compare methods for utilising new screening technology, validating novel drug targets, improving lead optimisation and making better use of discovery data.

Enjoy unparalleled networking opportunities. The two-day congress format combines dedicated networking breaks, pre-organised 1-2-1 meetings and our popular drinks reception. The exhibition hall and poster presentation spaces offer a relaxed and professional environment for discussion.

Tailor the congress experience.  The six stream agenda offers industry updates for those working in discovery technology, target-based discovery, discovery information, discovery chemistry, drug design, research strategy and open innovation.

Contact Danielle Dalby to download the agenda and for attendance information on d.dalby@oxfordgloabl.co.uk or call +44 (0)1865 248455



Further information
Scientific News
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Antarctic Sponge Extract Kills MRSA
New findings may provide opportunity for developing new drugs to fight dangerous bacteria currently highly resistant to treatment.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
Using Gene-editing Technology for Faster, Cheaper Antiviral Drug Development
UCLA scientists are working to develop special screening libraries based on a gene-editing technology called CRISPR.
Can Gender Play A Role In Determining Cancer Treatment Choices?
MD Anderson study reveals “sex-biased” gene signatures in review of 13 cancer types.
New Autism Blood Biomarker Identified
Researchers at UT Southwestern Medical Center have identified a blood biomarker that may aid in earlier diagnosis of children with autism spectrum disorder, or ASD.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!